ID   Ff-I14s04
AC   CVCL_C1DM
SY   Ff-I14 s04
DR   Wikidata; Q114311399
RX   PubMed=31497180;
RX   PubMed=35304548;
RX   PubMed=35755947;
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*52:01; DRB1*15:02 (PubMed=35755947).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1DX ! Ff-I01s01
OI   CVCL_C1DY ! Ff-I01s04
OI   CVCL_C1DZ ! Ff-I14s03
OI   CVCL_C1E0 ! QHJI01s01
OI   CVCL_C1E1 ! QHJI01s04
OI   CVCL_C1E2 ! QHJI14s03
OI   CVCL_C1DN ! QHJI14s04
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
RX   PubMed=31497180; DOI=10.1186/s41232-019-0106-0;
RA   Umekage M., Sato Y., Takasu N.;
RT   "Overview: an iPS cell stock at CiRA.";
RL   Inflamm. Regen. 39:17.1-17.5(2019).
//
RX   PubMed=35304548; DOI=10.1038/s41598-022-08753-5;
RA   Hiyoshi H., Sakuma K., Tsubooka-Yamazoe N., Asano S., Mochida T.,
RA   Yamaura J., Konagaya S., Fujii R., Matsumoto H., Ito R., Toyoda T.;
RT   "Characterization and reduction of non-endocrine cells accompanying
RT   islet-like endocrine cells differentiated from human iPSC.";
RL   Sci. Rep. 12:4740-4740(2022).
//
RX   PubMed=35755947; DOI=10.1016/j.omtm.2022.05.010;
RA   Kitano Y., Nishimura S., Kato T.M., Ueda A., Takigawa K., Umekage M.,
RA   Nomura M., Kawakami A., Ogawa H., Xu H.-G., Hotta A., Takasu N.,
RA   Tsukahara M.;
RT   "Generation of hypoimmunogenic induced pluripotent stem cells by
RT   CRISPR-Cas9 system and detailed evaluation for clinical application.";
RL   Mol. Ther. Methods Clin. Dev. 26:15-25(2022).
//